The Pharma Data

DECEMBER 28, 2020

28, 2020 /PRNewswire/ — Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia , today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021. SHANGHAI and SYDNEY , Dec. ” ABOUT NOVOTECH HEALTH HOLDINGS.

Clinical Trials 40

Clinical Trials Clinical Trials Research Analyst Trials 40

The Pharma Data

DECEMBER 31, 2020

Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. Zhang will be responsible for all aspects of financial management and work closely with Novotech Holdings’ executive team to support the growth of the business across Asia.

Gene Therapy 52

Gene Therapy Engineer Gene Research Analyst 52

XTalks

JUNE 9, 2022

Results of the study were published in the New England Journal of Medicine this month. XTALKS WEBINAR: All Means All: The Road to Inclusivity in Clinical Trials. Register for this free webinar to learn what the FDA’s new draft guidance means for diverse and inclusive trials. cm reduction, 10 mg a 19.4

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research Analyst 52